Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00332111 · ClinicalTrials.gov registry record

Infectious Outcomes Following Pancreas Transplantation

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
300
Enrollment target

NCT00332111 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 300 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00332111 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
300 participants
Enrollment target

Study Summary

The proposed protocol aims to characterize the infectious episodes in pancreas transplant recipients under the current medical care. Knowing these patients infectious risks, the types of infections that commonly affect them and the morbidity and mortality associated with it will provide valuable information in the evaluation of the safety and efficacy of the current practices. The information generated by this study will also serve as the basis for development of strategies targeting prophylaxis of infectious episodes.

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2006-04
Est. Completion 2008-09

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00332111

The ClinicalTrials.gov registry entry for NCT00332111 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00332111 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00332111 about?

NCT00332111 is a clinical study titled "Infectious Outcomes Following Pancreas Transplantation". The proposed protocol aims to characterize the infectious episodes in pancreas transplant recipients under the current medical care. Knowing these patients infectious risks, the types of infections that commonly affect them and the morbidity and mortality associated with it will provide valuable inf...

What is the current status of trial NCT00332111?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2006-04. Estimated completion is 2008-09.

Who is sponsoring clinical trial NCT00332111?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.